Update of TTD: Therapeutic Target Database

Overview

Journal Nucleic Acids Res

Publisher Oxford University Press

Specialty Biochemistry

Date 2009 Nov 26

PMID 19933260

Citations 129

Authors

Feng Zhu

Bucong Han

Pankaj Kumar

Xianghui Liu

Xiaohua Ma

Xiaona Wei

Lu Huang

Yangfan Guo

LianYi Han

Chanjuan Zheng

YuZong Chen

Affiliations

Soon will be listed here.

Abstract

Increasing numbers of proteins, nucleic acids and other molecular entities have been explored as therapeutic targets, hundreds of which are targets of approved and clinical trial drugs. Knowledge of these targets and corresponding drugs, particularly those in clinical uses and trials, is highly useful for facilitating drug discovery. Therapeutic Target Database (TTD) has been developed to provide information about therapeutic targets and corresponding drugs. In order to accommodate increasing demand for comprehensive knowledge about the primary targets of the approved, clinical trial and experimental drugs, numerous improvements and updates have been made to TTD. These updates include information about 348 successful, 292 clinical trial and 1254 research targets, 1514 approved, 1212 clinical trial and 2302 experimental drugs linked to their primary targets (3382 small molecule and 649 antisense drugs with available structure and sequence), new ways to access data by drug mode of action, recursive search of related targets or drugs, similarity target and drug searching, customized and whole data download, standardized target ID, and significant increase of data (1894 targets, 560 diseases and 5028 drugs compared with the 433 targets, 125 diseases and 809 drugs in the original release described in previous paper). This database can be accessed at http://bidd.nus.edu.sg/group/cjttd/TTD.asp.

Citing Articles

Unusual Genomic and Biochemical Features of sp. nov-A Novel Bacterial Species Isolated from Anthill Soil.

Dymova A, Kovalev M, Silantyev A, Borzykh A, Osipova P, Poddubko S Int J Mol Sci. 2025; 26(1.

PMID: 39795926 PMC: 11719660. DOI: 10.3390/ijms26010067.

Exploring potential therapeutic targets for asthma: a proteome-wide Mendelian randomization analysis.

Jiang Y, Wang Y, Guo J, Wang Z, Wang X, Yao X J Transl Med. 2024; 22(1):978.

PMID: 39472987 PMC: 11520847. DOI: 10.1186/s12967-024-05782-8.

The Potential of Dutasteride for Treating Multidrug-Resistant Infection.

Borgio J, Almandil N, Selvaraj P, John J, Alquwaie R, AlHasani E Pharmaceutics. 2024; 16(6).

PMID: 38931930 PMC: 11207579. DOI: 10.3390/pharmaceutics16060810.

Drug to genome to drug: a computational large-scale chemogenomics screening for novel drug candidates against sporotrichosis.

Santos A, Costa V, Freitas V, Dos Anjos L, de Almeida Santos E, Arantes T Braz J Microbiol. 2024; 55(3):2655-2667.

PMID: 38888692 PMC: 11405749. DOI: 10.1007/s42770-024-01406-x.

Draft genome sequence data of strain ORF15-23 from rice rhizosphere soil in Thailand.

Chinachanta K, Chaiwan F, Luu D, Pathom-Aree W Data Brief. 2024; 54:110466.

PMID: 38774239 PMC: 11106824. DOI: 10.1016/j.dib.2024.110466.

References

Ma X, Wang R, Yang S, Li Z, Xue Y, Wei Y . Evaluation of virtual screening performance of support vector machines trained by sparsely distributed active compounds. J Chem Inf Model. 2008; 48(6):1227-37. DOI: 10.1021/ci800022e. View

Dey R, Khan S, Saha B . A novel functional approach toward identifying definitive drug targets. Curr Med Chem. 2007; 14(22):2380-92. DOI: 10.2174/092986707781745523. View

Imming P, Sinning C, Meyer A . Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006; 5(10):821-34. DOI: 10.1038/nrd2132. View

Gerstein M . Measurement of the effectiveness of transitive sequence comparison, through a third 'intermediate' sequence. Bioinformatics. 1998; 14(8):707-14. DOI: 10.1093/bioinformatics/14.8.707. View

Zhu F, Han L, Zheng C, Xie B, Tammi M, Yang S . What are next generation innovative therapeutic targets? Clues from genetic, structural, physicochemical, and systems profiles of successful targets. J Pharmacol Exp Ther. 2009; 330(1):304-15. DOI: 10.1124/jpet.108.149955. View

Ohlstein E, Ruffolo Jr R, Elliott J . Drug discovery in the next millennium. Annu Rev Pharmacol Toxicol. 2000; 40:177-91. DOI: 10.1146/annurev.pharmtox.40.1.177. View

Chen X, Ji Z, Chen Y . TTD: Therapeutic Target Database. Nucleic Acids Res. 2001; 30(1):412-5. PMC: 99057. DOI: 10.1093/nar/30.1.412. View

Zheng C, Han L, Yap C, Ji Z, Cao Z, Chen Y . Therapeutic targets: progress of their exploration and investigation of their characteristics. Pharmacol Rev. 2006; 58(2):259-79. DOI: 10.1124/pr.58.2.4. View

Koehl P, Levitt M . Sequence variations within protein families are linearly related to structural variations. J Mol Biol. 2002; 323(3):551-62. PMC: 2692051. DOI: 10.1016/s0022-2836(02)00971-3. View

10.

Han L, Zheng C, Xie B, Jia J, Ma X, Zhu F . Support vector machines approach for predicting druggable proteins: recent progress in its exploration and investigation of its usefulness. Drug Discov Today. 2007; 12(7-8):304-13. DOI: 10.1016/j.drudis.2007.02.015. View

11.

Golden J . Prioritizing the human genome: knowledge management for drug discovery. Curr Opin Drug Discov Devel. 2003; 6(3):310-6. View

12.

Wishart D, Knox C, Guo A, Cheng D, Shrivastava S, Tzur D . DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2007; 36(Database issue):D901-6. PMC: 2238889. DOI: 10.1093/nar/gkm958. View

13.

Gao Z, Li H, Zhang H, Liu X, Kang L, Luo X . PDTD: a web-accessible protein database for drug target identification. BMC Bioinformatics. 2008; 9:104. PMC: 2265675. DOI: 10.1186/1471-2105-9-104. View

14.

Eichelbaum M, Ingelman-Sundberg M, Evans W . Pharmacogenomics and individualized drug therapy. Annu Rev Med. 2006; 57:119-37. DOI: 10.1146/annurev.med.56.082103.104724. View

15.

Giallourakis C, Henson C, Reich M, Xie X, Mootha V . Disease gene discovery through integrative genomics. Annu Rev Genomics Hum Genet. 2005; 6:381-406. DOI: 10.1146/annurev.genom.6.080604.162234. View

16.

Edwards A . Large-scale structural biology of the human proteome. Annu Rev Biochem. 2009; 78:541-68. DOI: 10.1146/annurev.biochem.78.070907.103305. View

17.

George R, Heringa J . Protein domain identification and improved sequence similarity searching using PSI-BLAST. Proteins. 2002; 48(4):672-81. DOI: 10.1002/prot.10175. View

18.

Zimmermann G, Lehar J, Keith C . Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov Today. 2007; 12(1-2):34-42. DOI: 10.1016/j.drudis.2006.11.008. View

19.

Jia J, Zhu F, Ma X, Cao Z, Cao Z, Li Y . Mechanisms of drug combinations: interaction and network perspectives. Nat Rev Drug Discov. 2009; 8(2):111-28. DOI: 10.1038/nrd2683. View

20.

Hopkins A . Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008; 4(11):682-90. DOI: 10.1038/nchembio.118. View